Gastric Balloon Market Size, Share, By Device (Single-balloon Systems, Dual-balloon Systems, Adjustable/Volume-Controlled Balloons, Capsule-based Balloons, and Others), Mode of Administration (Endoscopic Insertion, Swallowable Capsule, and Surgical/Minimally Invasive Laparoscopic), Filling Material [(Saline-Filled Balloons, Gas-Filled Balloons, and Hybrid (Liquid + Gas filled)], Duration [Short-term (< 6 months), Medium-term (6–12 months), Long-term and (12> months), End User (Hospitals, Ambulatory Surgical Centers, Bariatric & Weight-Loss Clinics, Specialized Gastroenterology Centers, and Others), and Region - Trends, Analysis, and Forecast till 2035

• 2024 Market Size: USD 122.1 Million
• 2035 Projected Market Size: USD 297.8 Million
• CAGR (2025-2035): 10.3%
• North America: Largest Market in 2024

Gastric balloons are minimally invasive, non-surgical devices that help people lose weight even when they are facing the problem of obesity. They are soft, stretchy balloons that are placed into the stomach endoscopically and inflated with saline or gas to fit into the stomach to make the patients feel fuller sooner and eat less. Gastric balloons usually are not permanent but stay in the stomach several months as a part of overall weight management program.

The gastric balloon industry is booming with the increasing global obesity trends, the growing popularity of non-invasive weight loss surgeries and the increasing awareness of the dangers of obesity against the health such as diabetes and heart diseases. The development of balloons, their safety, and favorable regulatory authorities continue to encourage uptake in patients and medical personnel. Also, a change in lifestyle and an increase in healthcare spending are increasing the demand of these minimally invasive solutions.

Gastric Balloon Import Data:

HSN Code	Device Description	Origin	Destination	Qty.	Price
90189099	ESO GASTRIC BALLOON RETRIEVAL DEVICE Length of spring-170cm,Diameter of spring-2.30mm,AS PER DOCUMENT	India	Colombia	5 NOS	USD 220.5
90189090	ALLURION GASTRIC BALLOON SYSTEMS COMPLETE WITH ACCESSORIES	United States	Indonesia	35 EA	USD 47,250
90189099	ADJUSTABLE BALLOON SYSTEM SPATZ3 INTRA GASTRIC BALLOON KIT SYSTEM	India	Sri Lanka	10 NOS	USD 5,988
90183990	8000016330-2409#&Gastric fistula feeding tube (thick balloon type) 24Fr.	Vietnam	Japan	92 PCE	USD 1,268.68

Gastric Balloon Export Data:

HSN Code	Device Description	Origin	Destination	Qty.	Price
902139900019	GASTRIC BALLOON (WITH ALL ITS DETAILEDED )	Russia	Turkey	400 SET	USD 89,566.02
90189099	ESO GASTRIC BALLOON RETRIEVAL DEVICESAMPLE FOR TENDERLENGTH OF SPRING170CM,DIAMETER OF SPRING-2.30MM,LENGTH OF CAP	India	Saudi Arabia	3 NOS	USD 117.6
90183990	9000009567-2407#&Nutrition tube in gastric fistula (Slightly thick balloon type with multi-purpose cap) 16FR.	Vietnam	Japan	307 PCE	USD 1,863.49
9021900000	GASTRIC BALLOON FOR APPETITE SUPPRESSION	France	Ecuador	13 UNT	USD 5,119.12

Current Industry Dynamics & Insights:

• North America has the largest gastric balloons market share, with almost 35.9%.
• The second-largest and fastest-growing area is Europe, by accounting for 27.2%.
• By Device, single-balloon systems holds the most market share for the gastric balloon market.
• On the account of mode of administration, endoscopic insertion are the most widely used gastric balloon in the market.

Drivers and Restraints:

Drivers	Restraints	Opportunities & Trends
Supportive regulatory approvals and clinical guidelines Advancements in gastric balloon technology and safety Expanding healthcare infrastructure	Limited long-term weight loss sustainability Low awareness in underdeveloped countries Stringent reimbursement policies in certain regions	Rising medical tourism for obesity treatments Increasing partnerships between manufacturers and clinics Growing investment in non-surgical obesity management solutions

Key Drivers:

Growing Obesity Risk Awareness Boosts Demand For Gastric Balloons.

Gastric balloon is gaining popularity due to increased awareness about obesity as a weight problem but more importantly it has been a leading cause of numerous health related complications. The more people get educated on the relationship between obesity and diabetes, heart disease, some forms of cancer, and even premature aging of organs, the more people seek to non-surgical remedies such as gastric balloons. This understanding compels patients to demand proactive interventions which are less invasive and safe and therefore the market becomes more open to new weight-management measures.

• For Instance, In 2023, a meta-analysis of 5,668 patients published in Cureus (via NCBI) reported that intragastric balloons (IGBs) produced an average total body weight loss of 11.1% and reduced HbA1c by 1.1%, showing significant benefits for obese patients and those at risk of diabetes. This highlights the way that the growth of awareness of the dangers of obesity is driving up the demand of safe and effective, non-surgical interventions such as the gastric balloons.

Restraints:

High Treatment Costs in Developing Regions

The high prices of gastric balloon surgeries continue to be a major obstacle in developing countries whereby healthcare funding is limited and many people cannot afford the surgeries due to lack of insurance. Another barrier to access is out-of-pocket costs, which makes market penetration an uphill task, even with the increase in obesity. This price barrier prevents greater growth in adoption and postpones the roll-out of improved non-surgical weight-loss systems.

• Counterbalance Statements: The issue of affordability is however slowly alleviating with the lowering prices of the device, the growing number of clinics in the country, and the trend of medical tourism. With increased awareness and increased competition among providers, the prices of treatment are possibly going to decrease, contributing to the increase in the gastric balloon market in the developing economies.

Opportunities & Trends:

Innovative Swallowable & Adjustable Gastric Balloons Open New Weight-Loss Pathways

Gastric balloons that can be swallowed and adjusted are changing the non-surgical weight-loss procedures. The devices do not require either endoscopy or anesthetic procedures, which enhances patient comfort and capability. Modifiable designs keep long term efficiency in customized volume management. The combinations of these innovations enable market to grow in terms of increased safety, convenience, and patient adoption.

• For instance, A 2023 multicenter trial (European Congress on Obesity) of 181 adults who used a swallowable gastric balloon containing liraglutide demonstrated an overall body weight loss of 18.7, excess weight loss of 99.4, and reduction of 6.4 kg/m2 BMI, and no serious adverse events. This illustrates the way that integrating ingestible balloons with pharmacotherapy can significantly improve the effect of weight-loss and the expansion of the market.

Device, mode of administration, filling material, duration, end user, and region are the divisions of the gastric balloon market.

By Device:

Single-balloon systems, dual-balloon systems, adjustable/volume-controlled balloons, capsule-based balloons, and others are device on which gastric balloon market is segmented. Single-balloon systems are the most popular since they are designed in a simple manner, have a good safety track record and they are easy to use. They are also less complex in their procedures, which is why they are a favorite among clinics and hospitals launching gastric balloon programs.

The second dominating models are adjustable. They are getting more popular, with customized therapy, and can be changed in volume, which enhances long-term comfort and efficacy. This flexibility allows the physicians to fine-tune the results of weight-loss, and does not involve premature removal or replacement.

By Mode of Administration:

Based on the mode of administration, the gastric balloon market is divided into endoscopic insertion, swallowable capsule, surgical/minimally invasive laparoscopic. Endoscopic insertion technique dominates the gastric balloon market share due to its accuracy and the experience that clinicians and patients have with the procedure. It also enables real-time visualization, whereby there is accurate placement and reduction of complications.

The second position occupies swallowable capsules as capsule-based placement is receiving traction by making the procedure simpler, no need of sedation and patients find it less threatening. It is non-invasive and thus very attractive to those who may be hesitant to go through the conventional endoscopic procedures.

• In June 2021, ProAct 360, the Allurion, Novozymes Feed s Alliance's ground-breaking second-generation protease, is now available for purchase. ProAct 360 raises the bar for poultry protease technology on three important fronts: sustainability, cost, and feed efficiency. This novel feed formulation offers quicker action, better matrix values for essential amino acids, and more consistent growth performance gains.

By Filling Material:

Saline-filled balloons, gas-filled balloons, and hybrid (liquid + gas filled), are filling material of the gastric balloon market. Saline is predominant as it is being preferred as it is safe and absorbs easily in the event of leakage as compared to other solvents and offers predictable performance. Its history of success gives it an added advantage over the other competitors in that the clinicians and patients all have confidence in it.

The second most dominant are the gas-filled balloons. These, though less popular, are lighter and possibly more comfortable to certain categories of patients. Patients are increasingly opting them as they provide lower levels of gastric pressure and overall experience.

• For instance, In a 2024 Kuwait-based study published in PubMed, Elipse and Orbera365 saline-filled gastric balloons were compared using a 358-patient average BMI of 35 kg/m2. Orbera365 led to greater weight loss (14.7 kg vs. 10 kg), while Elipse showed fewer early removals (3.4% vs. 9.7%). These findings highlight why saline-filled balloons are effective, safe, and remain the leading choice.

By Duration:

On the duration, gastric balloon market is categorized into short-term, medium-term, and long-term. Most common are short-term balloons that are less than or up to 6 months. They are very popular to use as they provide prompt results and are enrolled as temporary lifestyle redirects. Their shorter commitment duration will make them appealing to patients taking the first steps in the non-surgical weight-loss procedure.

Second most common are long-term balloons that take up to 12 months or more. Long term balloons which can be adjusted are popular among people who want long term, lasting effects without a premature withdrawal. The opportunity to control the amount of air in the balloon progressively aids in enhanced results and patient satisfaction.

• For instance, In a 2025 multicenter study published with SpringerLink of 522 patients undergoing the swallowable Allurion gastric balloon, the average weight loss of 13.9% was noted in four months with 95% maintained after 1 year. These non-procedural, short-term balloons have low intolerance (1.2%), and they have rare complications, which makes them popular and give them immediate and lasting results.

By End User:

Hospitals, ambulatory surgical centers, bariatric & weight-loss clinics, specialized gastroenterology centers, and others are end user of the gastric balloon market. Hospitals are at the forefront due to well-developed infrastructure, qualified personnel, and capacity to handle any complications. They can also access high-level imaging and support services and, therefore, are the main option when complex cases are involved.

Secondly most prevalent are the bariatric and weight-loss clinics that could be considered as the rising special clinics and include special programs that are dedicated to individual patient care and to more rapid access to emerging technologies. Such facilities are appealing to patients who want to find convenience and experience in one location.

Regional Insights:

Geographically, the gastric balloon market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America: This region leads gastric balloon market growth due to its developed health care system, knowledge of non-surgical weight-loss options, and innovativeness in adopting new medical equipment. The high penetration of competent networks of specifically targeted clinics and competent professionals in the region is also a motivating factor.

Although the region has a strong market presence, post-disruption of healthcare services similar to the recent incidents, some of the challenges in the region include high procedural costs, lack of uniform reimbursement policies and lagging of elective procedures.

• U.S. Gastric Balloon Market Insights:

The U.S. continues to be the most important player in North America due to the increased patient preference of obesity surgeries that are less invasive and the presence of gastric balloon surgery that was technologically advanced.

Europe: The second-largest and fastest-growing area is Europe. The European market is doing well in the gastric balloon market due to the rise in the degree of obesity and the growing need to find safer, more reversible alternative to bariatric surgery. Adoption is also increased by public health programs that promote weight management solutions.

The changes in healthcare policies, fragmented regulatory systems and perceived reimbursement pathways within various European countries slows down market growth.

• Germany Gastric Balloon Market Insights:

Germany is the European gastric balloon market leader as it has high rates of clinical adoption, developed healthcare system, and an increasing number of patients who are aware of the non-invasive methods of weight-loss. Favorable government policies and availability of large device manufacturers also help to reinforce the dominance of Germany in the region.

Asia Pacific: The fastest expanding market in terms of gastric balloon is Asia Pacific; due to urbanization, lifestyle shift, medical tourism and the growing awareness on non-surgical weight-loss procedures. Rising obesity rates and a growing middle-class population seeking affordable weight-loss solutions are accelerating market adoption. Government initiatives to curb obesity and expanding healthcare infrastructure are further supporting regional growth.

The factors that moderate adoption include disparate healthcare infrastructure, reduced density of specialty obesity management centers, and inadequate patient awareness in rural locations.

• China Gastric Balloon Market Insights:

China is at the forefront of growth in the region, and the population is starting to pay increasing attention to the health of the general population by focusing on preventive actions against obesity and the increased interest in the least invasive methods of weight loss, including the use of gastric balloons.

Gastric Balloon Market Report Scope:

Attribute	Details
Market Size 2025	USD 132.5 Million
Projected Market Size 2035	USD 297.8 Million
CAGR Growth Rate	10.3% (2025-2035)
Base year for estimation	2024
Forecast period	2025 – 2035
Market representation	Revenue in USD Million & CAGR from 2025 to 2035
Regional scope	North America - U.S. and Canada Europe – Germany, U.K., France, Russia, Italy, Spain, Netherlands, and Rest of Europe Asia Pacific – China, India, Japan, Australia, Indonesia, Malaysia, South Korea, and Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, and Rest of Latin America Middle East & Africa – GCC, Israel, South Africa, and Rest of Middle East & Africa
Company Landscape	Market Share Analysis of Companies Heat Map Analysis Company Overview, Devices Overview Financial Information, Key Highlights Business Strategies Overview SWOT Analysis
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Value Added Data Infosets	Besides fundamental market insights such as the size of the market, growth rate, segmentation, regional study, and key players, our reports carry value-added data sets such as trade flow (import-export) analysis, Deviceion and consumption overview, price trend evaluation, supply and value chain mapping, and raw Filling Material availability. Moreover, we provide strategic tools as PESTLE and Porter’s Five Forces analysis, examination of the regulatory landscape, as well as monitoring of technology and innovation thereby providing a comprehensive overview which facilitates sensible and anticipatory decision-making.

Segmentation:

By Device:

• Single-balloon Systems
• Dual-balloon Systems
• Adjustable/Volume-Controlled Balloons
• Capsule-based Balloons
• Others

By Mode of Administration:

• Endoscopic Insertion
• Swallowable Capsule
• Surgical/Minimally Invasive Laparoscopic

By Filling Material:

• Saline-Filled Balloons
• Gas-Filled Balloons
• Hybrid (Liquid + Gas filled)

By Duration:

• Short-term ( < 6 months)
• Medium-term (6–12 months)
• Long-term (12 > months)

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Bariatric & Weight-Loss Clinics
• Specialized Gastroenterology Centers
• Others

By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • Indonesia
  • Malaysia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Companies must aim at coming up with safer, no-procedure devices that attract more patients to fuel the growth of the gastric balloon market. Educational efforts in clinicians and patients can increase the awareness of non-invasive weight-loss programs. The collaborative approach with hospitals and obesity clinics will help to increase product coverage; at the same time, the investment in localized production will decrease expenditures on the new markets. The key players operating in the gastric balloon market include, Boston Scientific Corporation, Helioscopie, Spatz FGIA Inc., and others.

Gastric Balloon Market Companies:

• Allurion
• Boston Scientific Corporation
• ReShape Lifesciences, Inc.
• Spatz FGIA Inc.
• Medispar NV
• Districlass Médical
• Helioscopie
• Suzhou Shenyun Medical Equipment Co., Ltd
• Endalis
• Bariatric Solutions GmbH
• Signel Biomedical Private Limited
• COUSIN SURGERY
• Beijing ZKSK Technology Co.,Ltd.
• Torrance Bariatric Institute
• SILIMED INDUSTRIA DE IMPANTES LTDA

View an Additional List of Companies in the Gastric Balloon Market

• In July 2025, ReShape Lifesciences has announced the impending grant of U.S. Patent on its new intragastric balloon system. The patent introduces a swallowable and degradable balloon with self-sealing fill valve and natural excretion ability which adds to the intellectual property of the company. This is an advancement that boosts the competitiveness of ReShape in the non-surgical technologies of weight-loss, granting it patent protection until at least 2031.
• In September 2022, Allurion introduced its swallowable gastric balloon capsule in India, the first and the only swallowable weight-loss balloon in the world. This device is a non-surgical option to control obesity fully approved by the Central Drugs Standard Conhttps://medtimo.com/trol Organization (CDSCO). This is projected to create a need to adopt the use of more advanced solutions to weight-loss in the bariatric care market, which is expanding in India.

Analyst View:

The world gastric balloon market has been enjoying steady growth due to the increased obesity rates, the increased demand of non-surgical weight-loss options, and the increased use of innovative intragastric devices. Innovations such as degradable and swallowable balloon are enhancing convenience and safety of patients, driving market penetration. Good R&D platforms, growing healthcare facilities and favorable regulatory certifications will further propel the adoption. The major competitors are putting an emphasis on innovation of products and regional diversification as a way of enhancing their competitiveness.

Analysis of Sources:

Primary Sources:

• In-depth interviews
• Company-specific data
• Surveys and questionnaires
• Focus group discussions (FGDs)
• Others

Secondary Sources:

• PubMed (National Library of Medicine)
• Wiley Online Library
• National Institutes of Health (NIH)
• American Society for Metabolic and Bariatric Surgery (ASMBS)
• Others

More Related Reports

Polylaminate Capsule Market
Intragastric Balloon Market
Empty Capsules Market
Coffee pods and Capsules Market
Gastric Cancer Treatment Market

Company Name	Product Portfolio
Boston Scientific Corporation	Orber intragastric balloon system
ReShape Lifesciences, Inc.	Dual lumen gastric balloon catheter
Spatz FGIA Inc.	Adjustable gastric balloon
Medispar NV	Intragastric balloon
Districlass Médical	Adjustable intragastric prosthesis